Jefferies Lifts Immunogen (IMGN) PT by $7 on Better Kadcyla Pricing
Tweet Send to a Friend
Jefferies raised its price target on Buy-rated Immunogen Inc. (NASDAQ: IMGN) from $17 to $21 after the company and Roche ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
